Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EBO | Ann: EBOS announces appointment of new Chief Financial Officer | 26/04/24 | 0 | 42 | |||
|
|||||||
EBO | Ann: Capital Change Notice - Employee Share Plan | 12/04/24 | 0 | 62 | |||
|
|||||||
EBO | Ann: Ongoing Disclosure Notice - DRP shares | 02/04/24 | 0 | 47 | |||
|
|||||||
EBO | Ann: Performance Rights Update | 02/04/24 | 0 | 58 | |||
|
|||||||
EBO | Ann: Ongoing Disclosure Notices | 13:46 | 0 | 66 | |||
|
|||||||
EBO | Ann: Capital Change Notice - DRP shares | 22/03/24 | 0 | 53 | |||
|
|||||||
EBO | Ann: Capital Change Notice - Employee Share Plan | 15/03/24 | 0 | 65 | |||
|
|||||||
EBO | Ann: DRP Strike Price | 13/03/24 | 0 | 52 | |||
|
See All Discussions